Lannett Company Inc. (fka LCINQ)

[HIM]

$LCI : Broadfin Capital more than Doubles Stake in Lannett Co. to 5.1%


Posted July 19, 2011
By Richard Rabicoff

http://newyork.citybizlist.com/18/2011/7/19/Broadfin-Capital-more-than-Doubles-Stake-in-Lannett-Co.-to-5.1--cbl.aspx

NEW YORK -- Broadfin Capital, LLC reported in an SEC filing that it owns 1,441,707 shares or 5.1 percent of the common stock of Lannett Company, Inc. (AMEX: LCI).

That more than doubles Broadfin's stake, which was 2.29 percent as of March 31, 2011. The firm's shares are worth $6.78 million at Lannett's Tuesday closing price of $4.70.

Lannett, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of indications. The company is led Arthur Bedrosian, president and chief executive officer.

Broadfin is a New York hedge fund, founded by Kevin Kotler in 2005. He previously worked at Kevin's interest in medical technology goes back to his pre-med days at Furman Selz, UBS, ING, and The Galleon Group.

SEC filing: http://tinyurl.com/3l6po46